Jim Simons
BIOA

Jim Simons’s BioAge Labs BIOA Stock Holding History

Jim Simons’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42M Buy
138,588
+120,188
+653% +$2.31M ﹤0.01% 1799
2025
Q4 		$243K Sell
18,400
-124,600
-87% -$1.1M ﹤0.01% 2836
2025
Q3 		$841K Buy
143,000
+53,704
+60% +$251K ﹤0.01% 2574
2025
Q2 		$369K Buy
+89,296
New +$360K ﹤0.01% 2973

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Jim Simons's BIOA Position: Q1 2026 in Review

Jim Simons increased its BioAge Labs (BIOA) stake by 653% in Q1 2026, buying an estimated $2.31M and bringing the position to 138,588 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

Jim Simons first reported a position in BIOA in Q2 2025 and has held it in 4 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Jim Simons held 138,588 shares of BioAge Labs worth $2.42M as of Q1 2026.
  • Jim Simons bought 120,188 BioAge Labs shares in Q1 2026, an estimated $2.31M.
  • BioAge Labs made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1799 holding.
  • Jim Simons first reported a position in BioAge Labs in Q2 2025 and has held it in 4 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.